Denise Devore‐Carter

Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.

Thomas L. Ortel, Denise Devore‐Carter, Mary Ann Quinn-Allen et al. · Journal of Biological Chemistry · 1992 · 111 citations · Full text

Medicine, Biochemistry, Molecular Biology +17

Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting region

William H. Kane, Denise Devore‐Carter, Thomas L. Ortel · Biochemistry · 1990 · 54 citations

Life Sciences, Genetics, Molecular Biology +5

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.

Thomas L. Ortel, Mary Ann Quinn-Allen, L Charles et al. · Journal of Clinical Investigation · 1992 · 46 citations · Full text

Medicine, Hematology, Pathology +17

An accessory protein identical to mouse egasyn is complexed with rat microsomal beta-glucuronidase and is identical to rat esterase-3.

Sukumar Medda, Kohei Takeuchi, Denise Devore‐Carter et al. · Journal of Biological Chemistry · 1987 · 45 citations · Full text

Life Sciences, Biochemistry, Genetics +10

In situ hybridization for cytokine mRNA with digoxigenin-labeled riboprobes Sensitivity of detection and double label applications

Laurel J. Karr, Angela Panoskaltsis‐Mortari, Jimin Li et al. · Journal of Immunological Methods · 1995 · 26 citations

Life Sciences, Immunology, Molecular Biology +6